Final Launch Event of the Imperial-LMS Drug Discovery Hub at South Kensington

The Imperial-LMS Drug Discovery Hub recently concluded its third and final launch event, held at the historic South Kensington campus. With around 60 attendees from both academia and the biotech industry, the event was a valuable opportunity to share ideas, showcase the Hub’s cutting-edge capabilities, and explore future collaborations in drug discovery.

Engaging Discussions and Case Studies

The event opened with a warm welcome from Paul Freemont, setting the stage for an afternoon of insightful talks. Our speakers, Andrew Edwards, Jesus Gil, and Niklas Feldhahn, each presented compelling case studies that demonstrated the impact of the Hub’s resources on translational research. Their presentations highlighted how our advanced screening technologies can support research in areas such as infectious diseases, oncology, and immune responses.

Attendees were also introduced to the Hub’s screening capabilities, which are designed to accelerate the early stages of drug discovery. These technologies allow for high-throughput and high-content screening, providing researchers with powerful tools to identify potential therapeutic targets efficiently.

Thank You to Our Attendees and Speakers

We would like to extend our heartfelt thanks to everyone who attended the event, and especially to our speakers for their insightful contributions. The discussions that took place throughout the day were inspiring, and we look forward to seeing where these new ideas and connections will lead.

Get in Touch

As we move forward, we remain committed to fostering partnerships that push the boundaries of translational research. If you’re interested in exploring potential collaborations or learning more about what the Imperial-LMS Drug Discovery Hub has to offer, we encourage you to reach out and collaborate!